Search research articles
Contact Us
Filters
Showing results (881-890 of 916) with videos related to
Page
of 92
Sort By:
American Journal of Epidemiology
|
May 15, 2012
Guillain-Barre syndrome during the 2009-2010 H1N1 influenza vaccination campaign: population-based surveillance among 45 million Americans
Matthew E Wise, Melissa Viray, James J Sejvar, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 29, 2019
Phase Ib study of atezolizumab combined with cobimetinib in patients with solid tumors
M D Hellmann, T-W Kim, C B Lee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 19, 2023
Randomized Phase II Trial of Endocrine Therapy With or Without Ribociclib After Progression on Cyclin-Dependent Kinase 4/6 Inhibition in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer: MAINTAIN Trial
Kevin Kalinsky, Melissa K Accordino, Codruta Chiuzan, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
October 15, 2025
Screening rare genetic diagnoses for amenability to bespoke antisense oligonucleotide therapy development: A retrospective cohort study
David Cheerie, Marlen C Lauffer, Logan Newton, et al.
Journal of Breast Imaging
|
February 5, 2021
Factors Affecting Image Quality and Lesion Evaluability in Breast Diffusion-weighted MRI: Observations from the ECOG-ACRIN Cancer Research Group Multisite Trial (A6702)
Jennifer G Whisenant, Justin Romanoff, Habib Rahbar, et al.
JAMA Neurology
|
April 4, 2022
Subcortical Neuronal Correlates of Sleep in Neurodegenerative Diseases
Jun Y Oh, Christine M Walsh, Kamalini Ranasinghe, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 5, 2020
A randomized phase III trial comparing adjuvant single-agent S1, S-1 with oxaliplatin, and postoperative chemoradiation with S-1 and oxaliplatin in patients with node-positive gastric cancer after D2 resection: the ARTIST 2 trial<sup>☆</sup>
S H Park, D H Lim, T S Sohn, et al.
ESMO Open
|
August 27, 2022
Margetuximab with retifanlimab as first-line therapy in HER2+/PD-L1+ unresectable or metastatic gastroesophageal adenocarcinoma: MAHOGANY cohort A
D V T Catenacci, Y-K Kang, H H Yoon, et al.
Radiology
|
November 17, 2020
Mean Apparent Diffusion Coefficient Is a Sufficient Conventional Diffusion-weighted MRI Metric to Improve Breast MRI Diagnostic Performance: Results from the ECOG-ACRIN Cancer Research Group A6702 Diffusion Imaging Trial
Elizabeth S McDonald, Justin Romanoff, Habib Rahbar, et al.
Immunity
|
February 10, 2019
Clonal Deletion of Tumor-Specific T Cells by Interferon-γ Confers Therapeutic Resistance to Combination Immune Checkpoint Blockade
Chien-Chun Steven Pai, John T Huang, Xiaoqing Lu, et al.
Page
of 92
Search research articles
Search
Showing results (881-890 of 916) with videos related to
Sort By:
Page
of 92
American Journal of Epidemiology
|
May 15, 2012
Guillain-Barre syndrome during the 2009-2010 H1N1 influenza vaccination campaign: population-based surveillance among 45 million Americans
Matthew E Wise, Melissa Viray, James J Sejvar, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 29, 2019
Phase Ib study of atezolizumab combined with cobimetinib in patients with solid tumors
M D Hellmann, T-W Kim, C B Lee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 19, 2023
Randomized Phase II Trial of Endocrine Therapy With or Without Ribociclib After Progression on Cyclin-Dependent Kinase 4/6 Inhibition in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer: MAINTAIN Trial
Kevin Kalinsky, Melissa K Accordino, Codruta Chiuzan, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
October 15, 2025
Screening rare genetic diagnoses for amenability to bespoke antisense oligonucleotide therapy development: A retrospective cohort study
David Cheerie, Marlen C Lauffer, Logan Newton, et al.
Journal of Breast Imaging
|
February 5, 2021
Factors Affecting Image Quality and Lesion Evaluability in Breast Diffusion-weighted MRI: Observations from the ECOG-ACRIN Cancer Research Group Multisite Trial (A6702)
Jennifer G Whisenant, Justin Romanoff, Habib Rahbar, et al.
JAMA Neurology
|
April 4, 2022
Subcortical Neuronal Correlates of Sleep in Neurodegenerative Diseases
Jun Y Oh, Christine M Walsh, Kamalini Ranasinghe, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 5, 2020
A randomized phase III trial comparing adjuvant single-agent S1, S-1 with oxaliplatin, and postoperative chemoradiation with S-1 and oxaliplatin in patients with node-positive gastric cancer after D2 resection: the ARTIST 2 trial<sup>☆</sup>
S H Park, D H Lim, T S Sohn, et al.
ESMO Open
|
August 27, 2022
Margetuximab with retifanlimab as first-line therapy in HER2+/PD-L1+ unresectable or metastatic gastroesophageal adenocarcinoma: MAHOGANY cohort A
D V T Catenacci, Y-K Kang, H H Yoon, et al.
Radiology
|
November 17, 2020
Mean Apparent Diffusion Coefficient Is a Sufficient Conventional Diffusion-weighted MRI Metric to Improve Breast MRI Diagnostic Performance: Results from the ECOG-ACRIN Cancer Research Group A6702 Diffusion Imaging Trial
Elizabeth S McDonald, Justin Romanoff, Habib Rahbar, et al.
Immunity
|
February 10, 2019
Clonal Deletion of Tumor-Specific T Cells by Interferon-γ Confers Therapeutic Resistance to Combination Immune Checkpoint Blockade
Chien-Chun Steven Pai, John T Huang, Xiaoqing Lu, et al.
Page
of 92